血清HE4、血小板检测联合MRI对子宫内膜癌肌层浸润的研究进展
Advances in Serum HE4 and Platelet Detection Combined with MRI in the Treatment of Endometrial Carcinoma
DOI: 10.12677/ACM.2021.116384, PDF,   
作者: 李冬梅：山东第一医科大学，山东 济南；王苏荣：临沂市人民医院妇科，山东 临沂
关键词: 子宫内膜癌；HE4；血小板；磁共振；肌层浸润；Endometrial Cancer； HE4； Platelet； MRI； Muscular Infiltration
摘要: 子宫内膜癌(EC)是女性生殖系统三大恶性肿瘤之一，近年来，其发病率及病死率有逐渐升高且呈年轻化趋势。准确评估浸润深度和术前分期对于子宫内膜癌患者是很重要的。作为新型的肿瘤标志物HE4，在早期EC诊断及预后中可以作为一个有用的血清学标记。血小板参数的改变可协助子宫内膜癌病情评估及预后判断。磁共振(MRI)检查在EC宫颈受累及肌层浸润深度有良好的敏感度与特异度。因此本文将对肿瘤标志物HE4、血小板参数及MRI在子宫内膜癌肌层浸润中的意义进行叙述。
Abstract: Endometrial cancer (EC) is one of the three malignant tumors of the female reproductive system. In recent years, its incidence and mortality have been increasing gradually and at a younger age. Accurate assessment of infiltration depth and preoperative staging is important for patients with endometrial cancer. As a novel tumor marker HE4, it can be used as a useful serological marker in early EC diagnosis and prognosis. The changes of platelet parameters can assist the assessment and prognosis of endometrial cancer. Magnetic resonance imaging (MRI) showed good sensitivity and specificity in EC cervical involvement and muscle infiltration depth. Therefore, the significance of tumor marker HE4, platelet parameters and MRI in muscular invasion of endometrial carcinoma will be described in this paper.
文章引用：李冬梅, 王苏荣. 血清HE4、血小板检测联合MRI对子宫内膜癌肌层浸润的研究进展[J]. 临床医学进展, 2021, 11(6): 26256-2662. https://doi.org/10.12677/ACM.2021.116384

参考文献

[1] Colombo, N., Creutzberg, C., Amant, F., et al. (2016) ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-Up. Annals of Oncology, 27, 16-41. [Google Scholar] [CrossRef] [PubMed]
[2] Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[3] Guo, Y., Wang, P., Wang, P., et al. (2017) Myometrial Invasion and Overall Staging of Endometrial Carcinoma: Assessment Using Fusion of T2-Weighted Magnetic Resonance Imaging and Diffusion-Weighted Magnetic Resonance Imaging. OncoTargets and Therapy, 10, 5937-5943. [Google Scholar] [CrossRef] 
[4] Jingjing, H., Rui, J. and Hui, P. (2019) Adjuvant Chemoradiotherapy vs. Radiotherapy Alone in Early-Stage High-Risk Endometrial Cancer: A Systematic Review and Meta-Analysis. European Review for Medical and Pharmacological Sciences, 23, 833-840.
[5] 包媛媛, 洛若愚. 子宫内膜癌早期筛查与诊断研究进展[J]. 医学综述, 2020, 26(1): 76-80+85.
[6] Reijnen, C., IntHout, J., Massuger, L., et al. (2019) Diagnostic Accuracy of Clinical Biomarkers for Preoperative Prediction of Lymph Node Metastasis in Endometrial Carcinoma: A Systematic Review and Meta-Analysis. Oncologist, 24, e880-e890. [Google Scholar] [CrossRef] [PubMed]
[7] Bagaria, M., Shields, E. and Bakkum-Gamez, J.N. (2017) Novel Approaches to Early Detection of Endometrial Cancer. Current Opinion in Obstetrics and Gynecology, 29, 40-46. [Google Scholar] [CrossRef] 
[8] 谢玲玲, 林荣春, 林仲秋. 国际权威子宫内膜癌诊治指南解读[J]. 实用妇产科杂志, 2020, 36(6): 428-432.
[9] Dewan, R., Dewan, A., Hare, S., Bhardwaj, M. and Mehrotra, K. (2017) Diagnostic Performance of Serum Human Epididymis Protein 4 in Endometrial Carcinoma: A Pilot Study. Journal of Clinical and Diagnostic Research, 11, XC01-XC05. [Google Scholar] [CrossRef] 
[10] Hu, L., Du, S., Guo, W., Chen, D. and Li, Y. (2016) Comparison of Serum Human Epididymis Protein 4 and Carbohydrate Antigen 125 as Markers in Endometrial Cancer: A Meta-Analysis. International Journal of Gynecological Cancer, 26, 331-340. [Google Scholar] [CrossRef] 
[11] Li, J., Wang, X., Qu, W., Wang, J. and Jiang, S.W. (2019) Comparison of Serum Human Epididymis Protein 4 and CA125 on Endometrial Cancer Detection: A Meta-Analysis. Clinica Chimica Acta, 488, 215-220. [Google Scholar] [CrossRef] [PubMed]
[12] Fanfani, F., Restaino, S., Cicogna, S., et al. (2017) Preoperative Serum Human Epididymis Protein 4 Levels in Early Stage Endometrial Cancer: A Prospective Study. International Journal of Gynecological Cancer, 27, 1200-1205. [Google Scholar] [CrossRef] 
[13] 方旖骅, 颜士杰. 血清人附睾蛋白4检测对子宫内膜癌诊断的临床意义[J]. 安徽医学, 2015, 36(9): 1068-1071.
[14] Bignotti, E., Ragnoli, M., Zanotti, L., et al. (2011) Diagnostic and Prognostic Impact of Serum HE4 Detection in Endometrial Carcinoma Patients. British Journal of Cancer, 104, 1418-1425. [Google Scholar] [CrossRef] [PubMed]
[15] 刘若男, 苏宁, 侯艺芳, 李秀荣, 曲金荣, 王莉. 血清CA125和HE4联合盆腔MR检查在子宫内膜癌中的临床意义[J]. 医药论坛杂志, 2016, 37(9): 18-20.
[16] 姜伟丽. 血清人附睾分泌蛋白4、糖类抗原125与子宫内膜癌肌层浸润深度的相关性分析[J]. 中国民康医学, 2018, 30(6): 45-46.
[17] Song, J., Lai, X., Zhang, Y., Zheng, X. and Su, J. (2019) Preoperative Platelet Morphology Parameters as Prognostic Predictors for Endometrial Malignant Carcinoma Stage and Progesterone Receptor. Medicine (Baltimore), 98, e17818. [Google Scholar] [CrossRef] 
[18] Temur, I., Kucukgoz Gulec, U., Paydas, S., Guzel, A., Sucu, M. and Vardar, M.A. (2018) Prognostic Value of Pre-Operative Neutrophil/Lymphocyte Ratio, Monocyte Count, Mean Platelet Volume, and Platelet/Lymphocyte Ratio in Endometrial Cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology, 226, 25-29. [Google Scholar] [CrossRef] [PubMed]
[19] Pergialiotis, V., Oikonomou, M., Damaskou, V., et al. (2018) Platelet to Lymphocyte and Neutrophil to Lymphocyte Ratio as Predictive Indices of Endometrial Carcinoma: Findings from a Retrospective Series of Patients and Meta-Analysis. Journal of Gynecology Obstetrics and Human Reproduction, 47, 511-516. [Google Scholar] [CrossRef] [PubMed]
[20] 李萌萌. 术前血小板参数对子宫内膜癌的诊断价值及与临床病理特征的相关性分析[D]: [硕士学位论文]. 延吉: 延边大学, 2019.
[21] 窦倩如, 张晓敏, 刘芹, 王璇, 张英姿. 血小板参数与子宫内膜增生及子宫内膜癌的关系[J]. 现代妇产科进展, 2019, 28(4): 279-282.
[22] 蔡东阁, 赵刚, 赵晓桂, 闫桂花, 王倩. 子宫内膜癌患者不同病期血小板参数变化及其临床意义[J]. 山西医科大学学报, 2016, 47(4): 377-380.
[23] 李碧岚, 王晓珺, 黄宇佳, 叶磊, 严沁, 万小平. 联合检测血小板和CA125对子宫内膜癌的诊断价值[J]. 江苏医药, 2020, 46(7): 676-680.
[24] Yin, X.H., Jia, H.Y., Shi, M., Wu, H. and Li, Y.M. (2015) Magnetic Resonance Imaging for Detection of Depth of Myometrial Invasion and Cervical Invasion in Patients with Endometrial Carcinoma. International Journal of Clinical and Experimental Medicine, 8, 19501-19505.
[25] 张智, 陈红霞, 徐晓霞. 血清人附睾蛋HE4、CA125、CA199联合诊断子宫内膜癌的价值[J]. 实用医学杂志, 2016, 32(7): 1108-1111.
[26] Angioli, R., Plotti, F., Capriglione, S., et al. (2016) Preoperative Local Staging of Endometrial Cancer: The Challenge of Imaging Techniques and Serum Biomarkers. Archives of Gynecology and Obstetrics, 294, 1291-1298. [Google Scholar] [CrossRef] [PubMed]
[27] Zamani, N., Modares Gilani, M., Zamani, F. and Zamani, M.H. (2015) Utility of Pelvic MRI and Tumor Markers HE4 and CA125 to Predict Depth of Myometrial Invasion and Cervical Involvement in Endometrial Cancer. Journal of Family and Reproductive Health, 9, 177-183.
[28] 王安娜, 兰雪玲, 龙再秋. 人附睾蛋白4、糖类抗原125、增强MRI单独及联合检查对子宫内膜癌深肌层浸润诊断价值研究[J]. 临床军医杂志, 2020, 48(6): 691-694.
[29] 王恩力, 周坤, 刘淑梅, 任建新. 盆腔磁共振成像检查联合血清人附睾蛋白4水平检测对子宫内膜癌患者诊断效能的影响[J]. 广东医学, 2019, 40(20): 2886-2889.
[30] 施俊进, 康书朝, 徐鹏鹏. MRI检测方法在评估子宫内膜癌患者深肌层浸润中的作用[J]. 全科医学临床与教育, 2018, 16(6): 677-679.

为你推荐